Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

24 Nov 2020 07:00

RNS Number : 2423G
Devro PLC
24 November 2020
 

24 November 2020

Devro plc

 

Trading Update

 

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 July to 31 October 2020 (the "period").

Trading Update and Outlook

Trading in the period remained robust, despite the impact of COVID-19 on the food service channel, with collagen volumes growing and Group operating margins improving. As a result, our expectations for the full year remain unchanged.

Emerging markets continued to grow well in the period. Most mature markets grew, but this was more than offset by declines in Continental Europe and UK & Ireland mainly reflecting a weaker food service channel. For the full year we still expect good growth in emerging markets to offset a decline in our mature markets leading to broadly flat collagen volumes, with an estimated 2% net negative impact from COVID-19.

The Bellshill site closure and transfer of production lines to the Czech site remain on track.

On the 13 November 2020 Group net debt was £123.8m. In line with our normal seasonal cash generation we expect net debt to improve by year-end, to a similar level as of 30 June 2020, with the covenant net debt / underlying EBITDA ratio less than 2x. We expect strong cash generation in 2021 to drive leverage down further.

The interim dividend, announced in July, of 2.7p will be paid to shareholders on 15 January 2021. As previously announced the postponed 2019 final dividend of 6.3p, was paid in the form of a second interim dividend in October 2020.

Rutger Helbing, Chief Executive, said:

"We continued to make good underlying progress in the period. While we expect market conditions to remain challenging for the rest of the year we remain on track to deliver against our expectations. This is testament to the contribution of our people and I would again like to put on the record my gratitude for all their hard work. All sites remain open and we continue to provide good service to our customers and fulfil our role in the food supply chain."

ENDS 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Jackie Callaway

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain

Nick Hasell

Tel: 020 3727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLTLTLVFII
Date   Source Headline
29th Nov 20225:23 pmRNSDirector/PDMR Shareholding
29th Nov 20225:11 pmRNSForm 8.3 - Devro Plc
29th Nov 20223:28 pmRNSForm 8.3 - Devro plc
29th Nov 20223:24 pmBUSForm 8.3 - DEVRO PLC
29th Nov 20222:34 pmRNSForm 8.3 - DEVRO PLC
29th Nov 202212:47 pmRNSForm 8.3 - Devro plc
29th Nov 202211:23 amGNWForm 8.3 - [Devro plc - 28 11 2022] - (CGWL)
29th Nov 202211:15 amRNSForm 8.3 - Devro Plc
29th Nov 20229:58 amRNSForm 8.5 (EPT/RI) - Devro PLC
29th Nov 20229:45 amRNSForm 8.5 (EPT/RI)-Devro plc
29th Nov 20228:19 amRNSForm 8.3 - Devro PLC Amendment
28th Nov 20224:36 pmRNSForm 8.3 -Devro plc - Amendment
28th Nov 20223:21 pmRNSForm 8.3 - Devro Plc
28th Nov 20223:20 pmRNSForm 8.3 - Devro plc
28th Nov 20223:14 pmRNSForm 8.3 - Devro PLC
28th Nov 20223:03 pmRNSForm 8.3 - Devro plc
28th Nov 20222:59 pmRNSForm 8.3 - Devro PLC
28th Nov 20222:27 pmRNSForm 8.3 - Devro plc
28th Nov 20222:04 pmRNSForm 8.3 - Devro Plc
28th Nov 20221:45 pmRNSForm 8.3 - Devro PLC (closing postion)
28th Nov 20221:27 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
28th Nov 20221:13 pmRNSForm 8.3 - Devro plc
28th Nov 202212:50 pmRNSForm 8.3 - DEVRO PLC
28th Nov 202212:06 pmRNSForm 8.3 - Devro Plc
28th Nov 202212:01 pmRNSForm 8.3 - Devro Plc
28th Nov 202211:03 amBUSForm 8.3 - Devro plc
28th Nov 202210:51 amRNSForm 8.3 - Devro PLC
28th Nov 202210:39 amGNWForm 8.3 - [DEVRO PLC 25 11 2022] - CGWL
28th Nov 202210:29 amRNSForm 8.5 (EPT/RI) - Devro PLC
28th Nov 20229:18 amRNSForm 8.5 (EPT/NON-RI)-Devro plc
28th Nov 20229:16 amRNSForm 8.5 (EPT/RI)-Devro plc
25th Nov 20222:48 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Devro plc
25th Nov 202211:35 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - DEVRO PLC - Ordinary Shares
25th Nov 202210:51 amRNSForm 8.3 - Devro PLC
25th Nov 20229:31 amRNSForm 8.3 - Devro plc
25th Nov 20227:01 amRNSTrading Update
25th Nov 20227:00 amRNSRECOMMENDED CASH ACQUISITION
30th Sep 20222:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
12th Sep 20224:22 pmRNSHolding(s) in Company
2nd Aug 20227:00 amRNSHalf-year Report
29th Jul 20224:35 pmRNSDirector/PDMR Shareholding
27th Jul 20225:38 pmRNSDirector/PDMR Shareholding
11th May 202212:13 pmRNSDirector/PDMR Shareholding
29th Apr 20223:25 pmRNSTotal Voting Rights and Share Capital
28th Apr 20223:51 pmRNSResult of AGM
28th Apr 20227:00 amRNSAGM Trading Update
14th Apr 20222:22 pmRNSDirector/PDMR Shareholding
13th Apr 20226:10 pmRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSHolding(s) in Company
6th Apr 202212:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.